The Phase III 'High Five Trial' Five Fraction Radiation For High-Risk Prostate Cancer
The Phase III 'High Five Trial' Five Fraction Radiation For High-Risk Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
PRIMARY OBJECTIVE:
I. To compare metastasis-free survival, determined using conventional imaging, between men with high-risk prostate cancer randomized to ultrahypofractionation (stereotactic body radiation therapy [SBRT]) to those randomized to moderate hypofractionation and conventional fractionation.
SECONDARY OBJECTIVES:
I. To compare physician-reported toxicity as measured by Common Terminology Criteria for Adverse Events (CTCAE) version (v)5 between treatment arms.
II. To determine if ultrahypofractionation is non-inferior to moderate hypofractionation and conventional fractionation with respect to patient-reported urinary function (assessed by Expanded Prostate Cancer Index Composite [EPIC]-26 urinary domains).
III. To determine if ultrahypofractionation is non-inferior to moderate hypofractionation and conventional fractionation with respect to patient-reported bowel function (assessed by EPIC-26 bowel domain).
IV. To compare patient-reported fatigue (assessed by Patient Reported Outcomes Measurement Information System [PROMIS]-Fatigue) between treatment arms.
V. To compare failure-free survival between treatment arms. VI. To compare metastasis-free survival based on molecular imaging between treatment arms.
VII. To compare overall survival between treatment arms.
EXPLORATORY OBJECTIVES:
I. To compare patient-reported sexual function (assessed by EPIC-26 sexual domain) between treatment arms.
II. To compare patient-reported quality of life (assessed by European Quality of Life Five Dimension Five Level Scale Questionnaire [EQ-5D-5L]) between treatment arms.
III. To compare patient-reported treatment burden (assessed by COmprehensive Score for financial Toxicity (COST)) between treatment arms
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients undergo SBRT for a total of 5 treatments over 2 weeks in the absence of disease progression or unacceptable toxicity. Patients also undergo bone scan and/or computed tomography (CT), magnetic resonance imaging (MRI), or positron emission tomography (PET)/CT during screening and CT and/or MRI on study. Additionally, patients may optionally undergo blood and urine sample collection on study.
ARM II: Patients undergo external beam radiation treatment (EBRT) for 20-45 treatments over 4 to 9 weeks in the absence of disease progression or unacceptable toxicity. Patients also undergo bone scan and/or CT, MRI, or PET/CT during screening and CT and/or MRI on study. Additionally, patients may optionally undergo blood and urine sample collection on study.
Patients are followed up every 6 months for 5 years.
Inclusion Criteria:
Pathologically (histologically or cytologically) proven diagnosis of adenocarcinoma of prostate cancer
High-risk disease defined as having at least one or more of the following:
Prostate gland volume less than 100 cc prior to initiation of ADT as reported at time of biopsy or by separate measure with ultrasound or other imaging modalities including MRI or CT scan
No definitive clinical or radiologic evidence of metastatic disease outside of the pelvic nodes (M1a, M1b or M1c) on conventional imaging (i.e. bone scan, CT scan, MRI); Negative prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is an acceptable substitute
Age >= 18
Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2
No prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
No prior radical prostatectomy
No prior ablative or focal therapy to the prostate (including, but not limited to, transrectal or transurethral high-intensity focused ultrasound [HIFU], laser ablation, cryotherapy, irreversible electroporation [IRE], and vascular-targeted photodynamic therapy)
Prior pharmacologic androgen ablation for prostate cancer is allowed only if the onset of androgen ablation (both luteinizing hormone releasing hormone [LHRH] agonist and oral anti-androgen) is =< 185 days prior to registration; Please note: PSA prior to the start of any ADT will be used to define disease
No contraindication to prostate MRI (required for planning of radiotherapy in both arms)
Patients enrolled in NRG-GU009 must be enrolled in NRG-GU013 prior to radiation therapy treatment planning and start of radiation therapy
Birmingham, Alabama 35233, United States
gingerreeves@uabmc.edu
Irvine, California 92612, United States
Orange, California 92868, United States
Rancho Cordova, California 95670, United States
Roseville, California 95678, United States
Santa Clara, California 95051, United States
South San Francisco, California 94080, United States
Torrance, California 90505, United States
Wilmington, Delaware 19801, United States
Washington D.C., District of Columbia 20037, United States
Overland Park, Kansas 66210, United States
Topeka, Kansas 66606, United States
Louisville, Kentucky 40202, United States
Baltimore, Maryland 21287, United States
Columbia, Maryland 21044, United States
Easton, Maryland 21601, United States
Glen Burnie, Maryland 21061, United States
Milford, Massachusetts 01757, United States
South Weymouth, Massachusetts 02190, United States
Ann Arbor, Michigan 48106, United States
Brighton, Michigan 48116, United States
Brownstown, Michigan 48183, United States
CTOResearch@hfhs.org313-916-3721
Clinton Township, Michigan 48038, United States
Grand Rapids, Michigan 49503, United States
Royal Oak, Michigan 48073, United States
Saint Joseph, Michigan 49085, United States
Saint Joseph, Michigan 49085, United States
City of Saint Peters, Missouri 63376, United States
Lee's Summit, Missouri 64064, United States
Lebanon, New Hampshire 03756, United States
Elizabeth, New Jersey 07207, United States
Forest Hills, New York 11375, United States
Syracuse, New York 13210, United States
Toledo, Ohio 43606, United States
Wooster, Ohio 44691, United States
Chadds Ford, Pennsylvania 19317, United States
Harrisburg, Pennsylvania 17109, United States
Mechanicsburg, Pennsylvania 17050, United States
Pittsburgh, Pennsylvania 15232, United States
Wilkes-Barre, Pennsylvania 18711, United States
Sioux Falls, South Dakota 57117-5134, United States
American Fork, Utah 84003, United States
Berlin Corners, Vermont 05602, United States
Burlington, Vermont 05405, United States
Fishersville, Virginia 22939, United States
Mechanicsville, Virginia 23116, United States
Seattle, Washington 98195, United States
Johnson Creek, Wisconsin 53038, United States
Madison, Wisconsin 53718, United States
Madison, Wisconsin 53792, United States
Sheboygan, Wisconsin 53081, United States
Sturgeon Bay, Wisconsin 54235-1495, United States
Summit, Wisconsin 53066, United States
ncorp@aurora.org414-302-2304
West Bend, Wisconsin 53095, United States
Saint John, New Brunswick E2L 4L2, Canada
Montreal, Quebec H3H 2R9, Canada
Sherbrooke, Quebec J1H 5N4, Canada
tmyrick@uab.edu205-934-0220
800-338-2948
501-686-8274
Kpoct@kp.org877-642-4691
towercancerresearch@toweroncology.com
877-642-4691
Kpoct@kp.org877-642-4691
510-745-6433
Kpoct@kp.org877-642-4691
833-574-2273
Kpoct@kp.org877-642-4691
ucstudy@uci.edu877-827-8839
Cancer.trial.info@cshs.org310-423-2133
877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
ucstudy@uci.edu877-827-8839
Kpoct@kp.org877-642-4691
877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
courtney.steeneken@tmphysicians.com310-750-3300
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
Kpoct@kp.org877-642-4691
720-848-0650
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
719-365-2406
719-364-6700
720-848-0650
lbarone@christianacare.org302-623-4450
lbarone@christianacare.org302-623-4450
lbarone@christianacare.org302-623-4450
202-741-2210
yenrique@msmc.com305-674-2625
vhabayresearch@va.gov727-398-6661
clinicaltrials@jupitermed.com561-263-5791
Yvonne.Enriquez@msmc.com305-674-2625
ClinicalTrials@moffitt.org800-679-0775
ClinicalTrials@moffitt.org800-679-0775
ClinicalTrials@moffitt.org800-679-0775
ClinicalTrials@moffitt.org800-679-0775
ClinicalTrials@moffitt.org800-679-0775
404-778-1868
allyson.anderson@emory.edu404-251-2854
888-946-7447
404-778-1868
404-851-7115
clinicaltrialsoncology@dekalbmedical.org440-778-1868
i.webster@hawaiicancercare.com808-524-6115
808-532-0315
808-545-8548
808-522-4333
808-586-2979
808-531-8521
808-983-6090
808-535-7960
info@hawaiicancercare.com808-539-2273
808-486-6000
rohta@queens.org
618-463-7323
ncorp@aah.org
847-842-4847
andersonj@illinoiscancercare.com309-243-3605
andersonj@illinoiscancercare.com309-243-3605
cancer@northwestern.edu312-695-1301
312-355-3046
773-296-5360
advocateresearch@advocate.com630-929-6129
Research@Carle.com800-446-5532
morganthaler.jodi@mhsil.com217-876-4762
Donald.Smith3@nm.org630-352-5360
Barbara.barhamand@advocatehealth.com630-275-1270
Research@carle.com800-446-5532
morganthaler.jodi@mhsil.com217-876-4762
847-429-2907
Jrohde@emhc.org630-758-5460
andersonj@illinoiscancercare.com309-243-3605
Donald.Smith3@nm.org630-352-5360
708-799-9995
andersonj@illinoiscancercare.com309-243-3605
advocateresearch@advocatehealth.com630-929-6129
advocateresearch@advocatehealth.com630-929-6129
andersonj@illinoiscancercare.com309-243-3605
Research@carle.com800-446-5532
630-646-6075
morganthaler.jodi@mhsil.com217-876-4762
morganthaler.jodi@mhsil.com217-876-4762
nctnprogram_rhlccc@northwestern.edu
800-323-8622
andersonj@illinoiscancercare.com309-243-3605
ncorp@aah.org
847-384-3621
andersonj@illinoiscancercare.com309-243-3605
andersonj@illinoiscancercare.com309-243-3605
andersonj@illinoiscancercare.com309-243-3605
andersonj@illinoiscancercare.com309-243-3605
dschwab@wustl.edu314-747-9912
217-545-7929
pallante.beth@mhsil.com217-528-7541
Research@carle.com800-446-5532
Donald.Smith3@nm.org630-352-5360
cccois@goshenhealth.com574-364-2973
ksoder@mcfarlandclinic.com515-239-4734
KUCC_Navigation@kumc.edu913-588-3671
Stephanie.Norris@LMH.ORG785-505-2800
OlatheCCResearch@kumc.edu913-588-1569
KUCC_Navigation@kumc.edu913-588-3671
785-295-8000
KUCC_Navigation@kumc.edu913-588-3671
270-706-5470
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
ResearchInstituteInquiries@CommonSpirit.org720-874-1881
502-562-3429
ctoinfo@louisville.edu502-852-2755
clinicalresearch@marybird.com225-215-1353
clinicalresearch@marybird.com225-215-1353
Roster@nrgoncology.org412-339-5294
clinicalresearch@mainehealth.org207-396-8670
207-459-1600
clinicalresearch@mainehealth.org207-396-8670
info@mdproton.com410-369-5226
800-888-8823
800-463-6295
jhcccro@jhmi.edu410-955-8804
443-643-3010
443-546-1300
Christina.weisenborn@umm.edu410-822-1000
410-553-8100
Sarah.Larson@umm.edu301-755-4397
Jeanmarie.downing@umm.edu410-337-4569
617-724-5200
877-442-3324
877-332-4294
781-624-5000
MCRCwebsitecontactform@stjoeshealth.org734-712-7251
CancerAnswerLine@med.umich.edu800-865-1125
MCRCwebsitecontactform@stjoeshealth.org734-712-7251
800-865-1125
MCRCwebsitecontactform@stjoeshealth.org734-712-7251
MCRCwebsitecontactform@stjoeshealth.org734-712-7251
CTOResearch@hfhs.org313-916-3721
248-551-7695
CTOResearch@hfhs.org313-916-3721
wstrong@ghci.org810-762-8038
wstrong@ghci.org810-762-8038
crcwm-regulatory@crcwm.org616-391-1230
harsha.trivedi@umhsparrow.org517-364-3712
MCRCwebsitecontactform@stjoeshealth.org734-712-7251
616-391-1230
248-551-7695
MCRCwebsitecontactform@stjoeshealth.org734-712-7251
crcwm-regulatory@crcwm.org616-391-1230
crcwm-regulatory@crcwm.org616-391-1230
crcwm-regulatory@crcwm.org616-391-1230
248-551-7695
CTOResearch@hfhs.org313-916-3721
crcwm-regulatory@crcwm.org616-391-1230
OncologyClinicalTrialsFargo@sanfordhealth.org218-333-5000
CancerTrials@EssentiaHealth.org218-786-3308
mmcorc@healthpartners.com952-993-1517
mmcorc@healthpartners.com952-993-1517
CancerTrials@EssentiaHealth.org218-786-3308
CancerTrials@EssentiaHealth.org218-786-3308
CancerTrials@EssentiaHealth.org218-786-3308
CancerTrials@EssentiaHealth.org218-786-3308
kdean@slhduluth.com218-249-7825
mmcorc@healthpartners.com952-993-1517
218-786-3308
mmcorc@healthpartners.com952-993-1517
mmcorc@healthpartners.com952-993-1517
mmcorc@healthpartners.com952-993-1517
mmcorc@healthpartners.com952-993-1517
CancerTrials@EssentiaHealth.org218-786-3308
mmcorc@healthpartners.com952-993-1517
CancerTrials@EssentiaHealth.org218-786-3308
mmcorc@healthpartners.com952-993-1517
sfmc@sfmc.net573-334-2230
info@siteman.wustl.edu800-600-3606
info@siteman.wustl.edu800-600-3606
KUCC_Navigation@kumc.edu913-588-3671
KUCC_Navigation@kumc.edu913-588-3671
573-458-6379
research@phelpshealth.org573-458-7504
417-269-4520
info@siteman.wustl.edu800-600-3606
info@siteman.wustl.edu800-600-3606
314-996-5569
info@siteman.wustl.edu800-600-3606
314-251-7066
research@billingsclinic.org800-996-2663
mccinfo@mtcancer.org406-969-6060
Roster@nrgoncology.org412-339-5294
unmcrsa@unmc.edu402-559-6941
402-559-5600
unmcrsa@unmc.edu402-559-6941
cancer.research.nurse@dartmouth.edu800-639-6918
908-994-8000
Roster@nrgoncology.org412-339-5294
joanne.loeb@rwjbh.org973-322-2934
mary.danish@rwjbh.org732-923-6564
732-235-7356
732-235-7356
Christine.Kosmides@rwjbh.org973-926-7230
clinicaltrialsresearch@valleyhealth.com201-634-5792
clinicaltrials@capitalhealth.org609-394-4130
Lennette.Gonzales@rwjbh.org732-557-8294
HSC-ClinicalTrialInfo@salud.unm.edu505-925-0348
516-734-8896
Adg9003@nyp.org718-780-3677
585-396-6161
WCICTOresearch@urmc.rochester.edu
Roster@nrgoncology.org412-339-5294
718-520-6620
516-734-8896
516-734-8896
AMellor@northwell.edu914-666-1366
212-434-4460
516-734-8896
McDowelE@upstate.edu315-464-8230
BinghamE@upstate.edu315-464-3603
585-341-8113
585-275-5830
914-366-1600
800-862-2215
315-464-5476
BinghamE@upstate.edu315-464-3603
Roster@nrgoncology.org412-339-5294
McDowelE@upstate.edu315-464-8230
WCICTOresearch@urmc.rochester.edu
VHADURcancertrials@va.gov919-286-0411
lharrison@carolinaeasthealth.com252-634-6589
OncologyClinicalTrialsFargo@sanfordhealth.org701-234-6161
701-780-6520
CancerAnswer@ccf.org866-223-8100
800-641-2422
CTUReferral@UHhospitals.org800-641-2422
888-293-4673
ClinicalReserachDept@aultman.com330-363-7274
CTUReferral@UHhospitals.org800-641-2422
holly.henry@va.gov
ababal@metrohealth.org216-778-7559
TaussigResearch@ccf.org866-223-8100
TaussigResearch@ccf.org866-223-8100
Jamesline@osumc.edu800-293-5066
Jennifer.Sexton@ohiohealth.com614-788-3860
Jennifer.Sexton@ohiohealth.com614-788-3860
Jennifer.Sexton@ohiohealth.com614-788-3860
Jennifer.Sexton@ohiohealth.com614-788-3860
Jennifer.Sexton@ohiohealth.com614-788-3860
Jennifer.Sexton@ohiohealth.com614-788-3860
TaussigResearch@ccf.org866-223-8100
Jennifer.Sexton@ohiohealth.com614-788-3860
TaussigResearch@ccf.org866-223-8100
Jennifer.Sexton@ohiohealth.com614-788-3860
TaussigResearch@ccf.org866-223-8100
CTUReferral@UHhospitals.org800-641-2422
CTUReferral@UHhospitals.org800-641-2422
CTUReferral@UHhospitals.org800-641-2422
TaussigResearch@ccf.org866-223-8100
TaussigResearch@ccf.org866-223-8100
PCIOncResearch@promedica.org419-824-1842
PCIOncResearch@promedica.org419-824-1842
TaussigResearch@ccf.org866-223-8100
ou-clinical-trials@ouhsc.edu405-271-8777
nosall@stcharleshealthcare.org541-706-2909
CanRsrchStudies@providence.org503-215-2614
CanRsrchStudies@providence.org503-215-2614
CanRsrchStudies@providence.org503-215-2614
information@kpchr.org503-335-2400
haneydl@upmc.edu412-389-5208
Roster@nrgoncology.org412-339-5294
lbarone@christianacare.org302-623-4450
Roster@nrgoncology.org412-339-5294
HemonCCTrials@geisinger.edu570-271-5251
717-721-4840
ClinicalResearchServices@upmc.edu412-864-7716
Roster@nrgoncology.org412-339-5294
877-441-7957
724-838-1900
klitchfield@PINNACLEHEALTH.org717-724-6765
CTO@hmc.psu.edu717-531-3779
doxenberg@wellspan.org717-741-8303
HemonCCTrials@geisinger.edu570-374-8555
haneydl@upmc.edu412-389-5208
Roster@nrgoncology.org412-339-5294
412-647-2811
412-784-4900
412-647-8073
412-621-2334
412-367-6454
412-502-3920
HemonCCTrials@geisinger.edu800-275-6401
610-988-9323
HemonCCTrials@geisinger.edu570-271-5251
877-441-7957
877-441-7957
dorie.sturgill@mcleodhealth.org843-777-0770
kmertz-rivera@gibbscc.org864-560-6104
nmcgaha@selfregional.org864-725-4771
kmertz-rivera@gibbscc.org864-560-6104
kmertz-rivera@gibbscc.org864-560-6104
kmertz-rivera@gibbscc.org864-560-6104
OncologyClinicalTrialsSF@SanfordHealth.org605-312-3320
askmdanderson@mdanderson.org866-632-6789
210-916-4837
askmdanderson@mdanderson.org866-632-6789
askmdanderson@mdanderson.org877-632-6789
askmdanderson@mdanderson.org877-632-6789
askmdanderson@mdanderson.org877-632-6789
officeofresearch@imail.org801-855-4100
officeofresearch@imail.org435-868-5680
cancerinfo@hci.utah.edu888-424-2100
officeofresearch@imail.org435-716-6400
officeofresearch@imail.org801-507-3950
officeofresearch@imail.org801-387-7426
officeofresearch@imail.org801-357-7965
officeofresearch@imail.org801-507-3950
cancerinfo@hci.utah.edu888-424-2100
cancerinfo@hci.utah.edu888-424-2100
officeofresearch@imail.org801-408-1347
officeofresearch@imail.org833-321-3332
802-225-5400
rpo@uvm.edu802-656-4101
rpo@uvm.edu802-656-8990
cancer.research.nurse@hitchcock.org800-639-6918
540-332-5960
anne_carmellat@bshsi.org804-893-8978
CTOclinops@vcu.edu
anne_carmellat@bshsi.org804-893-8978
anne_carmellat@bshsi.org804-893-8978
Anne_caramella@bshsi.org804-893-8978
ctoclinops@vcu.edu
CTOclinops@vcu.edu804-628-6430
achapman1@peacehealth.org360-788-8223
800-804-8824
206-606-5800
800-804-8824
Christina.Cole@chhi.org304-399-6566
cancertrialsinfo@hsc.wvu.edu304-293-7374
cancertrialsinfo@hsc.wvu.edu304-293-7374
304-243-6442
Juli.Alford@aspirus.org715-623-9869
CancerTrials@EssentiaHealth.org218-786-3308
CancerTrials@EssentiaHealth.org218-786-3308
ncorp@aurora.org414-302-2304
ncorp@aurora.org414-302-2304
ncorp@aurora.org414-302-2304
WI_research_admin@hshs.org920-433-8889
ncorp@aurora.org414-302-2304
CancerTrials@EssentiaHealth.org218-786-3308
clinicaltrials@cancer.wisc.edu800-622-8922
ncorp@aurora.org414-302-2304
clinicaltrials@cancer.wisc.edu800-622-8922
clinicaltrials@cancer.wisc.edu800-622-8922
ncorp@aurora.org414-302-2304
262-257-5100
ncorp@aurora.org414-302-2304
ncorp@aurora.org414-302-2304
414-805-3666
ncorp@aurora.org414-302-2304
888-469-6614
mmcorc@healthpartners.com952-993-1517
414-805-0505
ncorp@aurora.org414-302-2304
ncorp@aurora.org414-302-2304
Beth.Knetter@aspirus.org715-847-2353
wi_research_admin@hshs.org920-433-8889
wi_research_admin@hshs.org920-433-8889
ncorp@aurora.org414-302-2304
CancerTrials@EssentiaHealth.org218-786-3308
Beth.Knetter@aspirus.org715-847-2353
wi_research_admin@hshs.org920-433-8889
701-364-6272
ncorp@aurora.org414-302-2304
877-405-6866
ncorp@aurora.org414-302-2304
ncorp@aurora.org414-302-2304
414-805-0505
715-422-7718
506-648-6890
613-761-4395
416-480-5000
clinical.trials@uhn.on.ca416-946-4501
514-252-3400 ext. 3329
info.cr.chum@ssss.gouv.qc.ca514-890-8000 ext. 12725
evelyn.ortega@muhc.mcgill.ca514-934-1934 ext. 48354
rechclinique@crchuq.ulaval.ca
crcinformation.chus@ssss.gouv.qc.ca819-820-6480
41 62 838 60 50